Acceptance-based Healthy Lifestyles Program for Patients With Pneumoconiosis

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial status changed: Unknown → Completed Show 5 more changesShow less
    • Primary completion date changed from estimate of Aug 2025 to Aug 31, 2025
    • Study completion date changed from estimate of Jan 2026 to Jan 31, 2026
    • Secondary endpoints: details revised at 2 of 6 entries
    • Site details revised
    • Eligibility criteria expanded, about 5 words
  2. Minor Changed Registry marked status Unknown; last known: Recruiting
  3. Notable Trial status: Not Yet Recruiting to Unknown
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 2024 to Nov 1, 2024
    v2
  4. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Symptoms, such as cough and shortness of breath, are common among patients with pneumoconiosis. Depression and anxiety can be elicited by the symptoms, while avoidance of daily activities is believed to reduce trigger of symptoms. The lung function is then declined and the risk of having stroke and heart failure is increased. The objectives of this 2-arm waitlist pilot randomized controlled trial are to test the effects and feasibility of an acceptance-based educational program among patients with pneumoconiosis. 80 participants will be recruited from community centers and randomly assigned to intervention group or waitlist-control group in a ratio of 1:1. The 6-week group-based educational program will be provided to the intervention group first, then the waitlist-control group. The program consists of 4 sessions integrated with acceptance components and care of pneumoconiosis. Their psychological health, healthy lifestyles, and cardiometabolic profiles will be assessed at baseline, week 6, and week 14. Data will be analyzed using a statistical package. The feasibility of the program will be evaluated by interview. The findings of this study can inform the integration of acceptance-based intervention into pneumoconiosis management in Hong Kong, and future study on chronic progressive lung diseases.
Trial Details
NCT Number NCT06563674
Lead Sponsor Chinese University of Hong Kong
Conditions
(from sponsor)
Pneumoconiosis, Healthy Lifestyle
Related terms Pneumoconiosis
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov